[Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
Lakartidningen. 2007 May 30-Jun 3;104(22):1684-8.
Lakartidningen. 2007.
PMID: 17601317
Swedish.
No abstract available.